Bioptimus Analysis: $41M Raised
What is Bioptimus?
Bioptimus specializes in developing a universal AI foundation model for biology. Their approach leverages extensive biological and multimodal data to uncover complex biological laws. This innovation aims to accelerate breakthroughs in biomedicine and environmental science.
Employees
11-50
Founded
2024
Industry
AI/ML, HealthTech, Biotech
Latest Funding Round Size
$41,000,000
Product Features & Capabilities
- H-optimus-1, a state-of-the-art foundation model for pathology
- M-optimus, a proprietary AI model for biological data
- Scalable computing environment with best-in-class GPUs
- Enhanced data security measures for safe data access
- Partnerships for diverse, multimodal data access.
Use Cases
Accelerate biomedical research using advanced AI models; Analyze complex biological data for scientific insights; Enhance pathology diagnostics with H-optimus-1; Securely manage large datasets for research; Collaborate with experts to pioneer AI in biology.
How much Bioptimus raised
Series A - $41,000,000
RecentOther Considerations
Assembled an elite scientific advisory board; Focused on large-scale foundation models; Collaborates with partners for diverse data access.
